Title
Category
Credits
Event date
Cost
- Research to Practice
- 1.00 Participation
$0.00
Young Whang, MD, from the UNC Lineberger Genitourinary Oncology group will describe relevant updates in systemic therapy for prostate cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
- Research to Practice
- 1.00 Participation
$0.00
This lecture is an interactive presentation and discussion to consider barriers to cancer clinical trial enrollment in North Carolina and potential approaches to address this. Topics will include the importance of patient and provider engagement, education and resources for identifying research opportunities and available trials, barriers and mitigation strategies to address population disparities in trial enrollment, and other issues.
- Research to Practice
- 1.00 Participation
$0.00
Dr. Benyam Muluneh from the UNC Eshelman School of Pharmacy will discuss relevant topics in cancer pharmacy for North Carolina cancer providers, such as adherence to oral anti-cancer therapies, evolving pharmaceutical practice models (e.g. specialized clinics), toxicity measurement and management, access, and other issues.
- Patient Centered Care
- 1.00 Participation
$0.00
Webinar DescriptionJulia Rodriguez-O’Donnell, LCSW, OSW-C, will discuss ethical and practical considerations related to providing care for undocumented patients with cancer, with particular attention to considerations relevant to cancer care in North Carolina.
If You Have to Ask, You Can’t Afford It: Addressing Financial Toxicity Among NC Cancer Patients SPOC
- Patient Centered Care
- 1.00 Participation
$0.00
Drs. Stephanie Wheeler and Don Rosenstein will discuss current concepts related to “financial toxicity” and how this applies to cancer care delivery in North Carolina. Current research including interventions in development to mitigate financial toxicity will also be reviewed.
- Patient Centered Care
- 1.00 Participation
$0.00
Dr. Hyman Muss will discuss recommendations related to specific needs of older patients with cancer. Updates will be presented regarding the implementation of the geriatric assessment into routine cancer care, as well as management strategies that are identified based on the results of the geriatric assessment.
- 1.00 Participation
$0.00
Dr. James from the UNC Anesthesiology Department in affiliation with UNC Lineberger cancer treatment group, will describe effects of regional and neuraxial perioperative blocks on cancer outcomes. Additional topical management considerations or recommendations for this patient population may also be presented.
- Patient Centered Care
- 1.00 Participation
$0.00
Cardio-oncology is a newly expanding area of cancer rehabilitation in the exercise world. As a Clinical Exercise Physiologist part of the Cardiac Rehabilitation team, Gabrielle Brennan, MS, ACSM EP-C, CET, has a Master of Science in Exercise Physiology with a specialization in Cancer Care. Previously, she worked as an Exercise Specialist as the program director for the LiveFit Cancer Exercise Program. She will explore the program and numerous benefits patients gained from this program. The American College of Sports Medicine guidelines for cancer patients will also be discussed.
- Research to Practice
- 1.00 Participation
$0.00
Dr. Christopher Dittus from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for rare lymphomas for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
- Research to Practice
- 1.00 Participation
$0.00
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021. Recent research advances in prostate, bladder, and kidney cancers utilizing new biomarkers and imaging tools, radiolabeled therapy, targeted therapy, immunotherapy and antibody-drug conjugates have led to new management approaches associated with significant improvements in patient outcomes.